CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | azoxystrobin |
|
Accession: | CHEBI:40909
|
browse the term
|
Definition: | An aryloxypyrimidine having a 4,6-diphenoxypyrimidine skeleton in which one of the phenyl rings is cyano-substituted at C-2 and the other carries a 2-methoxy-1-(methoxycarbonyl)vinyl substituent, also at C-2. An inhibitor of mitochondrial respiration by blocking electron transfer between cytochromes b and c1, it is used widely as a fungicide in agriculture. |
Synonyms: | exact_synonym: | methyl (2E)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyprop-2-enoate |
| related_synonym: | (alphaE)-2-[[6-(2-cyanophenoxy)-4-pyrimidinyl]oxy]-alpha-(methoxymethylene) benzeneacetic acid methyl ester; Formula=C22H17N3O5; InChI=1S/C22H17N3O5/c1-27-13-17(22(26)28-2)16-8-4-6-10-19(16)30-21-11-20(24-14-25-21)29-18-9-5-3-7-15(18)12-23/h3-11,13-14H,1-2H3/b17-13+; InChIKey=WFDXOXNFNRHQEC-GHRIWEEISA-N; SMILES=CO\\C=C(\\C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1; methyl (E)-2-[2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl]-3-methoxyacrylate |
| xref: | CAS:131860-33-8; KEGG:C18558 |
| xref_mesh: | MESH:C087670 |
| xref: | PDBeChem:AZO; PMID:20818521; PMID:21153804; PMID:21671616; PMID:21777591; PMID:21884765; PMID:22092932; PMID:22224459; PMID:22278367; PMID:24125711; PMID:24405376; PMID:24700092; PMID:24726979; PMID:25011117; PMID:25090100; PMID:25196149; PPDB:54; Patent:EP382375; Patent:US5395837; Pesticides:azoxystrobin; Reaxys:8350244; Wikipedia:Azoxystrobin |
|
|
|
G |
1700012B07Rkl |
RIKEN cDNA 1700012B07 gene like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of 1700012B07RKL gene |
CTD |
PMID:33854195 |
|
NCBI chr10:94,771,471...94,804,839
Ensembl chr10:94,771,554...94,804,839
|
|
G |
Aars1 |
alanyl-tRNA synthetase 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of AARS1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ABCA1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ABCC5 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
|
|
G |
Abcf3 |
ATP binding cassette subfamily F member 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ABCF3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr11:80,340,476...80,352,211
Ensembl chr11:80,339,977...80,352,211
|
|
G |
Abhd6 |
abhydrolase domain containing 6, acylglycerol lipase |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ABHD6 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr15:16,859,740...16,907,094
Ensembl chr15:16,859,738...16,906,985
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
increases phosphorylation multiple interactions |
ISO EXP |
azoxystrobin results in increased phosphorylation of ACACA protein dorsomorphin inhibits the reaction [azoxystrobin results in increased phosphorylation of ACACA protein] [azoxystrobin co-treated with Dietary Fats] affects the phosphorylation of ACACA protein |
CTD |
PMID:24726979 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
increases expression |
ISO |
azoxystrobin results in increased expression of ACADM mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ACADVL mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of ACAT2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ACOT2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACOT4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Actn1 |
actinin, alpha 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ACTN1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Acy1 |
aminoacylase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACY1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Adam12 |
ADAM metallopeptidase domain 12 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ADAM12 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:188,686,984...189,014,206
Ensembl chr 1:188,686,989...189,020,667
|
|
G |
Adam15 |
ADAM metallopeptidase domain 15 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAM15 gene |
CTD |
PMID:33854195 |
|
NCBI chr 2:174,754,629...174,765,136
Ensembl chr 2:174,754,633...174,765,113
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ADAM8 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
|
|
G |
Adamtsl3 |
ADAMTS-like 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:136,288,793...136,596,986
Ensembl chr 1:136,288,793...136,596,986
|
|
G |
Adcy6 |
adenylate cyclase 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ADCY6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:129,742,827...129,763,922
Ensembl chr 7:129,742,838...129,763,754
|
|
G |
Adrm1 |
ADRM1 26S proteasome ubiquitin receptor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ADRM1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:167,265,435...167,270,197
Ensembl chr 3:167,265,296...167,270,195
|
|
G |
Aen |
apoptosis enhancing nuclease |
increases expression |
ISO |
azoxystrobin results in increased expression of AEN mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
|
|
G |
Afp |
alpha-fetoprotein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of AFP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of AGT mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Ahcy |
adenosylhomocysteinase |
increases expression |
ISO |
azoxystrobin results in increased expression of AHCY mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
|
|
G |
Ahsa1 |
activator of Hsp90 ATPase activity 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of AHSA1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:106,913,296...106,921,347
Ensembl chr 6:106,913,530...106,921,345
|
|
G |
Aig1 |
androgen-induced 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of AIG1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:8,046,430...8,269,276
Ensembl chr 1:8,046,430...8,269,084
|
|
G |
Akap8 |
A-kinase anchoring protein 8 |
multiple interactions decreases expression |
EXP ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of AKAP8 mRNA azoxystrobin results in decreased expression of AKAP8 mRNA |
CTD |
PMID:33512557 PMID:33854195 |
|
NCBI chr 7:11,316,224...11,332,523
Ensembl chr 7:11,316,228...11,332,399
|
|
G |
Akap8l |
A-kinase anchoring protein 8 like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of AKAP8L mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:11,332,671...11,362,287
Ensembl chr 7:11,332,672...11,362,275
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of AKR1B1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr7a2 |
aldo-keto reductase family 7, member A2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of AKR7A2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
ISO |
azoxystrobin results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:32339800 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ALDH2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALDH9A1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
increases expression |
ISO |
azoxystrobin results in increased expression of ALDOA mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Alg2 |
ALG2, alpha-1,3/1,6-mannosyltransferase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALG2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:61,768,738...61,773,297
Ensembl chr 5:61,768,740...61,773,297
|
|
G |
Amdhd2 |
amidohydrolase domain containing 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of AMDHD2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:13,187,579...13,196,148
Ensembl chr10:13,187,578...13,196,095
|
|
G |
Amer1 |
APC membrane recruitment protein 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of AMER1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr X:60,300,595...60,316,480
Ensembl chr X:60,295,751...60,316,440
|
|
G |
Amz2 |
archaelysin family metallopeptidase 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of AMZ2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:94,401,546...94,412,116
Ensembl chr10:94,401,579...94,412,114
|
|
G |
Angptl4 |
angiopoietin-like 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANGPTL4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Anks3 |
ankyrin repeat and sterile alpha motif domain containing 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ANKS3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:10,614,953...10,635,815
Ensembl chr10:10,615,047...10,635,806
|
|
G |
Anxa11 |
annexin A11 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANXA11 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:1,412,373...1,457,814
Ensembl chr16:1,410,756...1,457,797
|
|
G |
Anxa2 |
annexin A2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ANXA2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Ap2m1 |
adaptor related protein complex 2 subunit mu 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of AP2M1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr11:80,355,307...80,364,218
Ensembl chr11:80,328,041...80,364,140
|
|
G |
Aplf |
aprataxin and PNKP like factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of APLF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:120,070,471...120,122,656
Ensembl chr 4:120,070,471...120,122,633
|
|
G |
Aplp1 |
amyloid beta precursor like protein 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of APLP1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:85,696,880...85,707,215
Ensembl chr 1:85,696,882...85,707,155
|
|
G |
Apof |
apolipoprotein F |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of APOF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:700,688...702,130
Ensembl chr 7:700,762...701,946
|
|
G |
Arf2 |
ADP-ribosylation factor 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ARF2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:88,867,836...88,889,654
Ensembl chr10:88,867,836...88,889,659
|
|
G |
Arf4 |
ARF GTPase 4 |
increases expression |
ISO |
azoxystrobin results in increased expression of ARF4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr16:1,896,692...1,913,267
Ensembl chr16:1,896,546...1,913,261
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ARG1 mRNA |
CTD |
PMID:32194361 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arhgap8 |
Rho GTPase activating protein 8 |
increases expression |
ISO |
azoxystrobin results in increased expression of ARHGAP8 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:115,842,223...115,902,094
Ensembl chr 7:115,850,654...115,902,093
|
|
G |
Arl4d |
ARF like GTPase 4D |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ARL4D mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
|
|
G |
Arpc1a |
actin related protein 2/3 complex, subunit 1A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ARPC1A gene |
CTD |
PMID:33854195 |
|
NCBI chr12:9,502,496...9,525,304
Ensembl chr12:9,502,501...9,525,330
|
|
G |
Arpp19 |
cAMP-regulated phosphoprotein 19 |
increases expression |
ISO |
azoxystrobin results in increased expression of ARPP19 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:75,779,640...75,802,474
Ensembl chr 8:75,779,523...75,802,452 Ensembl chr 8:75,779,523...75,802,452
|
|
G |
Arrdc4 |
arrestin domain containing 4 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ARRDC4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290
|
|
G |
Arsg |
arylsulfatase G |
affects expression |
ISO |
azoxystrobin affects the expression of ARSG mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:94,412,261...94,551,224
Ensembl chr10:94,447,399...94,542,941
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of ASAH1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
|
|
G |
Asb7 |
ankyrin repeat and SOCS box-containing 7 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:120,222,835...120,267,411
Ensembl chr 1:120,222,745...120,267,282
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ASF1B mRNA |
CTD |
PMID:33512557 |
|
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression |
ISO |
azoxystrobin results in increased expression of ASNS mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
multiple interactions increases expression |
EXP ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ASS1 mRNA azoxystrobin results in increased expression of ASS1 mRNA |
CTD |
PMID:33512557 PMID:33854195 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression |
ISO |
azoxystrobin results in increased expression of ATF4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf5 |
activating transcription factor 5 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ATF5 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atosa |
atos homolog A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ATOSA mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549
|
|
G |
Atp11c |
ATPase phospholipid transporting 11C |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ATP11C mRNA |
CTD |
PMID:33512557 |
|
NCBI chr X:138,564,459...138,752,116
Ensembl chr X:138,565,836...138,751,204
|
|
G |
Atp5f1c |
ATP synthase F1 subunit gamma |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ATP5F1C mRNA |
CTD |
PMID:33512557 |
|
NCBI chr17:68,423,927...68,446,169
Ensembl chr17:68,423,909...68,608,367
|
|
G |
Atp5mc1 |
ATP synthase membrane subunit c locus 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP5MC1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:81,024,056...81,026,780
Ensembl chr10:81,023,925...81,027,124 Ensembl chr10:81,023,925...81,027,124
|
|
G |
Atp5mk |
ATP synthase membrane subunit K |
increases expression |
ISO |
azoxystrobin results in increased expression of ATP5MK mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:245,973,910...245,980,702
Ensembl chr 1:245,973,914...245,980,761 Ensembl chr10:245,973,914...245,980,761
|
|
G |
Atp6v0d1 |
ATPase H+ transporting V0 subunit D1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP6V0D1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:33,403,352...33,447,357
Ensembl chr19:33,403,355...33,447,450
|
|
G |
Atp6v1b2 |
ATPase H+ transporting V1 subunit B2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ATP6V1B2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr16:20,617,515...20,641,651
Ensembl chr16:20,617,518...20,641,745
|
|
G |
Aurka |
aurora kinase A |
increases expression |
ISO |
azoxystrobin results in increased expression of AURKA mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
B2m |
beta-2 microglobulin |
increases expression |
ISO |
azoxystrobin results in increased expression of B2M mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
B3galt6 |
Beta-1,3-galactosyltransferase 6 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of B3GALT6 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:166,584,202...166,586,338
Ensembl chr 5:166,584,202...166,586,338
|
|
G |
Bag3 |
BAG cochaperone 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BAG3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Banf1 |
barrier to autointegration nuclear assembly factor 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of BANF1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:202,672,170...202,674,215
Ensembl chr 1:202,671,305...202,674,188
|
|
G |
Banp |
Btg3 associated nuclear protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BANP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:50,007,710...50,082,742
Ensembl chr19:50,007,881...50,082,738
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
azoxystrobin results in increased expression of BAX mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of BBC3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of BCL2L11 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl9 |
BCL9, transcription coactivator |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of BCL9 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:184,760,616...184,846,261
Ensembl chr 2:184,760,618...184,786,435
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BHMT mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Blcap |
BLCAP, apoptosis inducing factor |
decreases expression |
ISO |
azoxystrobin results in decreased expression of BLCAP mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:146,222,699...146,232,859
Ensembl chr 3:146,222,240...146,232,909
|
|
G |
Bmf |
Bcl2 modifying factor |
decreases expression |
ISO |
azoxystrobin results in decreased expression of BMF mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Brd2 |
bromodomain containing 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of BRD2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
|
|
G |
Brd3 |
bromodomain containing 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of BRD3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:10,773,163...10,829,675
Ensembl chr 3:10,775,272...10,829,577
|
|
G |
Brms1l |
BRMS1 like transcriptional repressor |
decreases expression |
ISO |
azoxystrobin results in decreased expression of BRMS1L mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:73,266,673...73,300,630
Ensembl chr 6:73,266,691...73,300,631
|
|
G |
Bzw2 |
basic leucine zipper and W2 domains 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of BZW2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:52,828,069...52,888,599
Ensembl chr 6:52,827,661...52,888,628
|
|
G |
C1qc |
complement C1q C chain |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C1QC mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
C1s |
complement C1s |
decreases expression |
ISO |
azoxystrobin results in decreased expression of C1S mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
|
|
G |
C2cd5 |
C2 calcium-dependent domain containing 5 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of C2CD5 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:175,969,544...176,055,597
Ensembl chr 4:175,969,545...176,055,558
|
|
G |
C8h11orf54 |
similar to human chromosome 11 open reading frame 54 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C8H11ORF54 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
|
|
G |
Calcoco1 |
calcium binding and coiled coil domain 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CALCOCO1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:133,834,705...133,849,515
Ensembl chr 7:133,834,707...133,849,422
|
|
G |
Calr |
calreticulin |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CALR mRNA |
CTD |
PMID:33512557 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CAMK2B mRNA |
CTD |
PMID:33512557 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CAMK2G mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:3,504,017...3,563,050
Ensembl chr15:3,504,085...3,563,050
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CAP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:135,142,108...135,168,885
Ensembl chr 5:135,142,112...135,168,769
|
|
G |
Caps |
calcyphosine |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CAPS mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:1,544,597...1,545,631
Ensembl chr 9:1,544,719...1,545,647
|
|
G |
Caps2 |
calcyphosine 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CAPS2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:47,580,636...47,641,598
Ensembl chr 7:47,581,137...47,639,229
|
|
G |
Casp3 |
caspase 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CASP3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cblb |
Cbl proto-oncogene B |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CBLB mRNA |
CTD |
PMID:33512557 |
|
NCBI chr11:48,589,878...48,756,940
Ensembl chr11:48,592,703...48,756,839
|
|
G |
Cbs |
cystathionine beta synthase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CBS mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Ccdc125 |
coiled-coil domain containing 125 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCDC125 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:31,809,120...31,835,538
Ensembl chr 2:31,809,228...31,850,152
|
|
G |
Ccdc92 |
coiled-coil domain containing 92 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CCDC92 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr12:31,796,102...31,823,333
Ensembl chr12:31,796,684...31,823,337
|
|
G |
Ccne2 |
cyclin E2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CCNE2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Ccng1 |
cyclin G1 |
increases expression |
ISO |
azoxystrobin results in increased expression of CCNG1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccnl1 |
cyclin L1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCNL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368
|
|
G |
Cd24 |
CD24 molecule |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CD24 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CD55 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
|
|
G |
Cdc20 |
cell division cycle 20 |
increases expression |
ISO |
azoxystrobin results in increased expression of CDC20 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc45 |
cell division cycle 45 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CDC45 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
|
|
G |
Cdca3 |
cell division cycle associated 3 |
increases expression |
ISO |
azoxystrobin results in increased expression of CDCA3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
|
|
G |
Cdh11 |
cadherin 11 |
increases expression |
ISO |
azoxystrobin results in increased expression of CDH11 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
|
|
G |
Cdh2 |
cadherin 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CDH2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdk5 |
cyclin-dependent kinase 5 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CDK5 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5 regulatory subunit 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CDK5R1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CDKN1A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
affects expression |
ISO |
azoxystrobin affects the expression of CDT1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
affects expression |
ISO |
azoxystrobin affects the expression of CEBPB mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CEBPD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
|
|
G |
Cel |
carboxyl ester lipase |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CEL mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:11,883,532...11,891,035
Ensembl chr 3:11,883,532...11,891,035
|
|
G |
Cenph |
centromere protein H |
increases expression |
ISO |
azoxystrobin results in increased expression of CENPH mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:31,896,675...31,910,179
Ensembl chr 2:31,894,667...31,910,154
|
|
G |
Cenpk |
centromere protein K |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CENPK mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706
|
|
G |
Cep57 |
centrosomal protein 57 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CEP57 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:10,669,588...10,689,257
Ensembl chr 8:10,669,590...10,689,249
|
|
G |
Cep85 |
centrosomal protein 85 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CEP85 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:146,356,571...146,404,155
Ensembl chr 5:146,356,576...146,404,060
|
|
G |
Cerk |
ceramide kinase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:117,225,855...117,269,436
Ensembl chr 7:117,225,855...117,268,759
|
|
G |
Cetn3 |
centrin 3 |
increases expression |
ISO |
azoxystrobin results in increased expression of CETN3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:12,089,025...12,101,828
Ensembl chr 2:12,089,226...12,101,828
|
|
G |
Cfb |
complement factor B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CFB mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Cfl1 |
cofilin 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CFL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Chchd10 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CHCHD10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:12,725,839...12,727,638
Ensembl chr20:12,725,842...12,732,763
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CHEK2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chmp6 |
charged multivesicular body protein 6 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CHMP6 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:105,191,972...105,197,642
Ensembl chr10:105,191,950...105,197,640
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CHRNA4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Cib1 |
calcium and integrin binding 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of CIB1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:134,178,331...134,183,895
Ensembl chr 1:134,178,331...134,213,423
|
|
G |
Cirbp |
cold inducible RNA binding protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CIRBP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CITED2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of CKS2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr17:13,570,611...13,575,770
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CLCF1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Clk2 |
CDC-like kinase 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CLK2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:174,570,614...174,582,645
Ensembl chr 2:174,570,653...174,588,985
|
|
G |
Clstn1 |
calsyntenin 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CLSTN1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:160,031,235...160,094,585
Ensembl chr 5:160,031,308...160,094,583
|
|
G |
Cltb |
clathrin, light chain B |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CLTB mRNA |
CTD |
PMID:33512557 |
|
NCBI chr17:10,001,512...10,019,201
Ensembl chr17:10,001,513...10,019,169
|
|
G |
Clu |
clusterin |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CLU mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cndp2 |
carnosine dipeptidase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:78,039,932...78,056,922
|
|
G |
Coa6 |
cytochrome c oxidase assembly factor 6 |
increases expression |
ISO |
azoxystrobin results in increased expression of COA6 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr19:54,395,746...54,398,348
Ensembl chr19:54,395,742...54,399,407
|
|
G |
Cox6b1 |
cytochrome c oxidase subunit 6B1 |
increases expression |
ISO |
azoxystrobin results in increased expression of COX6B1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:85,875,080...85,884,081
Ensembl chr 1:85,875,109...85,884,001 Ensembl chr 2:85,875,109...85,884,001 Ensembl chr 5:85,875,109...85,884,001
|
|
G |
Cox8a |
cytochrome c oxidase subunit 8A |
increases expression |
ISO |
azoxystrobin results in increased expression of COX8A mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:204,402,118...204,404,439
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CPT2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Crebbp |
CREB binding protein |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CREBBP mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CRY1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Cspp1 |
centrosome and spindle pole associated protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSPP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:9,077,161...9,192,402
Ensembl chr 5:9,077,161...9,193,377
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSRNP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Cth |
cystathionine gamma-lyase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of CTH gene |
CTD |
PMID:33854195 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctnnal1 |
catenin alpha-like 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CTNNAL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:71,514,340...71,569,431
Ensembl chr 5:71,514,340...71,569,431
|
|
G |
Ctsb |
cathepsin B |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CTSB mRNA |
CTD |
PMID:33512557 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Cux2 |
cut-like homeobox 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CXCR4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyc1 |
cytochrome c-1 |
increases expression |
ISO |
azoxystrobin results in increased expression of CYC1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:108,067,106...108,069,483
Ensembl chr 7:108,067,115...108,069,479
|
|
G |
Cycs |
cytochrome c, somatic |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CYCS mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions |
ISO |
azoxystrobin results in increased expression of CYP1A1 mRNA; azoxystrobin results in increased expression of CYP1A1 protein [cyproconazole co-treated with azoxystrobin] results in increased expression of CYP1A1 mRNA |
CTD |
PMID:21784029 PMID:29294346 PMID:32194361 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of CYP1A2 mRNA; azoxystrobin results in increased expression of CYP1A2 protein |
CTD |
PMID:21784029 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CYP26B1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions increases expression |
ISO |
[cyproconazole co-treated with azoxystrobin] results in increased expression of CYP2B6 protein azoxystrobin results in increased expression of CYP2B6 protein |
CTD |
PMID:29294346 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c22 |
cytochrome P450, family 2, subfamily c, polypeptide 22 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP2C22 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:238,991,698...239,031,323
Ensembl chr 1:238,991,610...239,021,738
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CYP2C19 protein |
CTD |
PMID:32194361 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions increases expression |
ISO |
[azoxystrobin co-treated with cyproconazole] results in increased expression of CYP3A4 protein; [cyproconazole co-treated with azoxystrobin] results in increased expression of CYP3A4 mRNA azoxystrobin results in increased expression of CYP3A4 mRNA |
CTD |
PMID:29294346 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases expression |
ISO |
azoxystrobin results in increased expression of CYP3A5 mRNA |
CTD |
PMID:34642769 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp4f1 |
cytochrome P450, family 4, subfamily f, polypeptide 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4F1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:12,010,850...12,022,497
Ensembl chr 7:12,010,852...12,022,046
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CYP7A1 mRNA; azoxystrobin results in decreased expression of CYP7A1 protein |
CTD |
PMID:32194361 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cytip |
cytohesin 1 interacting protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CYTIP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:42,698,058...42,774,955
Ensembl chr 3:42,698,768...42,725,993
|
|
G |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of DAAM1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:90,389,544...90,550,114
Ensembl chr 6:90,389,688...90,550,114
|
|
G |
Dach1 |
dachshund family transcription factor 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of DACH1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr15:74,528,122...74,909,811
Ensembl chr15:74,529,208...74,909,922
|
|
G |
Dad1 |
defender against cell death 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of DAD1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr15:27,677,286...27,697,120
Ensembl chr15:27,677,268...27,697,347
|
|
G |
Daxx |
death-domain associated protein |
decreases expression |
ISO |
azoxystrobin results in decreased expression of DAXX mRNA |
CTD |
PMID:33512557 |
|
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
|
|
G |
Dbndd2 |
dysbindin domain containing 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of DBNDD2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:153,216,300...153,220,651
Ensembl chr 3:153,191,090...153,220,651
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DBP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
|
|
G |
Dclre1c |
DNA cross-link repair 1C |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DCLRE1C mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:74,775,828...74,810,089
Ensembl chr17:74,776,935...74,809,186
|
|
G |
Dcx |
doublecortin |
decreases expression |
ISO |
azoxystrobin results in decreased expression of DCX mRNA |
CTD |
PMID:33512557 |
|
NCBI chr X:107,430,767...107,573,612
Ensembl chr X:107,430,767...107,507,476
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
azoxystrobin results in increased expression of DDIT3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of DDR1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
|
|
G |
Ddx20 |
DEAD-box helicase 20 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DDX20 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:193,158,761...193,168,484
Ensembl chr 2:193,158,823...193,166,774
|
|
G |
Ddx5 |
DEAD-box helicase 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DDX5 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:91,723,508...91,732,210
Ensembl chr10:91,723,508...91,732,283
|
|
G |
Decr1 |
2,4-dienoyl-CoA reductase 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of DECR1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:29,411,172...29,439,054
Ensembl chr 5:29,411,172...29,439,018
|
|
G |
Depdc1 |
DEP domain containing 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of DEPDC1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:248,684,508...248,717,951
Ensembl chr 2:248,684,523...248,717,951
|
|
G |
Depdc1b |
DEP domain containing 1B |
increases expression |
ISO |
azoxystrobin results in increased expression of DEPDC1B mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
|
|
G |
Dffb |
DNA fragmentation factor subunit beta |
multiple interactions decreases expression |
EXP ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DFFB mRNA azoxystrobin results in decreased expression of DFFB mRNA |
CTD |
PMID:33512557 PMID:33854195 |
|
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
|
|
G |
Dlg2 |
discs large MAGUK scaffold protein 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DLG2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DLL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:56,312,062...56,320,177
Ensembl chr 1:56,312,066...56,320,179
|
|
G |
Dmrt3 |
doublesex and mab-3 related transcription factor 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DMRT3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:223,244,340...223,264,254
Ensembl chr 1:223,248,747...223,262,530
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of DNAJB4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB9 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dnttip2 |
deoxynucleotidyltransferase, terminal, interacting protein 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of DNTTIP2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:210,374,321...210,386,366
Ensembl chr 2:210,374,289...210,385,581
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DPP4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dpy30 |
dpy-30 histone methyltransferase complex regulatory subunit |
increases expression |
ISO |
azoxystrobin results in increased expression of DPY30 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:21,120,947...21,141,720
Ensembl chr 6:21,120,947...21,141,432
|
|
G |
Drd2 |
dopamine receptor D2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of DRD2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DUSP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp11 |
dual specificity phosphatase 11 |
increases expression |
ISO |
azoxystrobin results in increased expression of DUSP11 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:118,367,673...118,385,183
Ensembl chr 4:118,368,053...118,385,181
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DUSP5 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DUSP6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of DYNLL1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
|
|
G |
Dzip1l |
DAZ interacting zinc finger protein 1-like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DZIP1L gene |
CTD |
PMID:33854195 |
|
NCBI chr 8:100,188,414...100,229,077
Ensembl chr 8:100,194,999...100,228,988
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of E2F1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
Eed |
embryonic ectoderm development |
increases expression |
ISO |
azoxystrobin results in increased expression of EED mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:143,867,875...143,895,008
Ensembl chr 1:143,867,875...143,894,974
|
|
G |
Eef1b2 |
eukaryotic translation elongation factor 1 beta 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of EEF1B2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:64,580,163...64,582,737
Ensembl chr 9:64,579,893...64,582,737
|
|
G |
Eef2k |
eukaryotic elongation factor-2 kinase |
decreases expression |
ISO |
azoxystrobin results in decreased expression of EEF2K mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:175,393,119...175,456,756
Ensembl chr 1:175,393,154...175,455,164
|
|
G |
Efna1 |
ephrin A1 |
increases expression |
ISO |
azoxystrobin results in increased expression of EFNA1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:174,681,676...174,689,061
Ensembl chr 2:174,681,682...174,690,866
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
decreases expression |
ISO |
azoxystrobin results in decreased expression of EIF2S1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif4b |
eukaryotic translation initiation factor 4B |
increases expression |
ISO |
azoxystrobin results in increased expression of EIF4B mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:133,206,637...133,228,436
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of EIF4EBP1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Elp1 |
elongator acetyltransferase complex subunit 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ELP1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:71,453,338...71,505,833
Ensembl chr 5:71,456,310...71,505,762
|
|
G |
Emilin1 |
elastin microfibril interfacer 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of EMILIN1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:25,455,974...25,463,713
Ensembl chr 6:25,445,298...25,463,698
|
|
G |
Emx2 |
empty spiracles homeobox 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of EMX2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:258,626,584...258,633,594
Ensembl chr 1:258,626,584...258,633,594
|
|
G |
Eno2 |
enolase 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ENO2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ENPP3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:20,563,700...20,635,044
Ensembl chr 1:20,563,697...20,635,041
|
|
G |
Ep300 |
E1A binding protein p300 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of EP300 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of EPB41L3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 9:109,056,178...109,260,607
Ensembl chr 9:109,016,113...109,260,607
|
|
G |
Epm2aip1 |
EPM2A interacting protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of EPM2AIP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:111,233,871...111,241,219
Ensembl chr 8:111,233,826...111,241,871
|
|
G |
Erf |
Ets2 repressor factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ERF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:80,829,935...80,838,388
Ensembl chr 1:80,829,935...80,838,388
|
|
G |
Esd |
esterase D |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ESD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
|
|
G |
Etfb |
electron transfer flavoprotein subunit beta |
increases expression |
ISO |
azoxystrobin results in increased expression of ETFB mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:93,851,908...93,866,072
Ensembl chr 1:93,851,858...93,866,068
|
|
G |
Etnk1 |
ethanolamine kinase 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ETNK1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:176,126,056...176,170,325
Ensembl chr 4:176,126,180...176,193,770
|
|
G |
Etv1 |
ETS variant transcription factor 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ETV1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:55,590,149...55,681,784
Ensembl chr 6:55,590,234...55,681,775
|
|
G |
Evl |
Enah/Vasp-like |
decreases expression |
ISO |
azoxystrobin results in decreased expression of EVL mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:127,473,119...127,594,342
Ensembl chr 6:127,474,543...127,594,344
|
|
G |
Exosc5 |
exosome component 5 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of EXOSC5 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:81,168,128...81,177,266
Ensembl chr 1:81,166,023...81,177,265
|
|
G |
Exosc8 |
exosome component 8 |
increases expression |
ISO |
azoxystrobin results in increased expression of EXOSC8 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928
|
|
G |
Fam135a |
family with sequence similarity 135, member A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:26,420,116...26,500,803
Ensembl chr 9:26,420,528...26,500,717
|
|
G |
Fam13a |
family with sequence similarity 13, member A |
decreases expression |
ISO |
azoxystrobin results in decreased expression of FAM13A mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:88,056,521...88,155,782
Ensembl chr 4:88,058,403...88,155,860
|
|
G |
Fam177a1 |
family with sequence similarity 177, member A1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM177A1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 6:72,632,628...72,647,553
Ensembl chr 6:72,632,623...72,647,553
|
|
G |
Fam204a |
family with sequence similarity 204, member A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:259,328,551...259,366,726
Ensembl chr 1:259,337,709...259,367,077
|
|
G |
Fam53a |
family with sequence similarity 53, member A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM53A gene |
CTD |
PMID:33854195 |
|
NCBI chr14:77,088,178...77,124,395
Ensembl chr14:77,090,723...77,124,395
|
|
G |
Fam72a |
family with sequence similarity 72, member A |
increases expression |
ISO |
azoxystrobin results in increased expression of FAM72A mRNA |
CTD |
PMID:33512557 |
|
NCBI chr13:42,967,701...42,979,083
Ensembl chr13:42,967,578...42,984,208
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions decreases expression |
ISO |
[azoxystrobin co-treated with Dietary Fats] affects the expression of FASN mRNA azoxystrobin results in decreased expression of FASN mRNA |
CTD |
PMID:24726979 PMID:33512557 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbxo7 |
F-box protein 7 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of FBXO7 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:17,809,224...17,837,549
Ensembl chr 7:17,809,231...17,837,530
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of FDFT1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fdps |
farnesyl diphosphate synthase |
increases expression |
ISO |
azoxystrobin results in increased expression of FDPS mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
|
|
G |
Ficd |
FIC domain protein adenylyltransferase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of FICD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:42,889,195...42,894,090
Ensembl chr12:42,889,194...42,894,070
|
|
G |
Fkbp4 |
FKBP prolyl isomerase 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of FKBP4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:161,703,379...161,711,833
Ensembl chr 4:161,703,379...161,711,833
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene |
CTD |
PMID:33854195 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Fmn1 |
formin 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FMN1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:100,101,103...100,485,652
Ensembl chr 3:100,134,549...100,479,220
|
|
G |
Foxo4 |
forkhead box O4 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of FOXO4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr X:66,385,241...66,392,115
Ensembl chr X:66,385,558...66,392,115
|
|
G |
Frmd4b |
FERM domain containing 4B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FRMD4B mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:129,895,401...130,222,070
Ensembl chr 4:129,895,708...130,084,197
|
|
G |
Fsd1 |
fibronectin type III and SPRY domain containing 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of FSD1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:818,241...821,761
Ensembl chr 9:818,263...828,185
|
|
G |
Fstl1 |
follistatin-like 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of FSTL1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr11:62,895,391...62,948,581
Ensembl chr11:62,779,783...62,948,677
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of FTL mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
|
|
G |
Fzd6 |
frizzled class receptor 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FZD6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:70,055,012...70,086,781
Ensembl chr 7:70,055,068...70,086,776
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of G6PC1 mRNA |
CTD |
PMID:32194361 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
decreases expression |
ISO |
azoxystrobin results in decreased expression of G6PD mRNA |
CTD |
PMID:33512557 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gaa |
alpha glucosidase |
decreases expression |
ISO |
azoxystrobin results in decreased expression of GAA mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:104,529,673...104,546,836
Ensembl chr10:104,529,747...104,546,836
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
decreases expression |
ISO |
azoxystrobin results in decreased expression of GADD45B mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GADD45G mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Gap43 |
growth associated protein 43 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of GAP43 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Gata2 |
GATA binding protein 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of GATA2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761
|
|
G |
Gatd3a |
glutamine amidotransferase class 1 domain containing 3A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GATD3A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
azoxystrobin results in increased expression of GCLM mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gdf15 |
growth differentiation factor 15 |
multiple interactions increases expression |
EXP ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GDF15 mRNA azoxystrobin results in increased expression of GDF15 mRNA |
CTD |
PMID:33512557 PMID:33854195 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gen1 |
GEN1 Holliday junction 5' flap endonuclease |
decreases expression |
ISO |
azoxystrobin results in decreased expression of GEN1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:33,947,599...33,978,461
Ensembl chr 6:33,948,206...33,978,401
|
|
G |
Get1 |
guided entry of tail-anchored proteins factor 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of GET1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr11:35,438,555...35,460,156
Ensembl chr11:35,445,815...35,459,973
|
|
G |
Gin1 |
gypsy retrotransposon integrase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GIN1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:98,293,596...98,315,155
Ensembl chr 9:98,293,597...98,315,848
|
|
G |
Git2 |
GIT ArfGAP 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GIT2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:41,829,717...41,872,621
Ensembl chr12:41,829,730...41,871,097
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of GJA1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Glb1 |
galactosidase, beta 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GLB1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
|
|
G |
Gli3 |
GLI family zinc finger 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of GLI3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr17:49,438,567...49,709,712
Ensembl chr17:49,438,567...49,709,712
|
|
G |
Glrx |
glutaredoxin |
decreases expression |
ISO |
azoxystrobin results in decreased expression of GLRX mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Gmnn |
geminin, DNA replication inhibitor |
increases expression |
ISO |
azoxystrobin results in increased expression of GMNN mRNA |
CTD |
PMID:33512557 |
|
NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054
|
|
G |
Gnpda2 |
glucosamine-6-phosphate deaminase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:38,520,663...38,538,713
Ensembl chr14:38,520,705...38,538,713
|
|
G |
Gpc1 |
glypican 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of GPC1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
|
|
G |
Gpr89b |
G protein-coupled receptor 89B |
increases expression |
ISO |
azoxystrobin results in increased expression of GPR89B mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:184,408,136...184,445,560
Ensembl chr 2:184,401,438...184,445,584
|
|
G |
Gprasp3 |
G protein-coupled receptor associated sorting protein family member 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GPRASP3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:98,847,591...98,854,949
Ensembl chr X:98,817,593...98,854,545
|
|
G |
Gramd1a |
GRAM domain containing 1A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GRAMD1A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:86,367,001...86,393,348
Ensembl chr 1:86,367,001...86,393,336
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of GRIA1 gene |
CTD |
PMID:33854195 |
|
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of GRIA2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GRINA mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Gsdma |
gasdermin A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of GSDMA gene |
CTD |
PMID:33854195 |
|
NCBI chr10:83,614,336...83,639,543
Ensembl chr10:83,627,051...83,639,543
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
ISO |
azoxystrobin results in increased expression of GSR mRNA |
CTD |
PMID:33512557 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GSTK1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
|
|
G |
Gucy2c |
guanylate cyclase 2C |
decreases expression |
ISO |
azoxystrobin results in decreased expression of GUCY2C mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:169,568,505...169,649,092
Ensembl chr 4:169,568,529...169,649,092
|
|
G |
Hapstr2 |
HUWE1 associated protein modifying stress responses 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of HAPSTR2 gene |
CTD |
PMID:33854195 |
|
NCBI chr X:138,922,089...138,924,124
Ensembl chr X:138,922,100...138,922,918
|
|
G |
Hars1 |
histidyl-tRNA synthetase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HARS1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr18:28,381,649...28,398,699
Ensembl chr18:28,381,655...28,398,740
|
|
G |
Haus1 |
HAUS augmin-like complex, subunit 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of HAUS1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr18:71,275,417...71,286,626
Ensembl chr18:71,273,537...71,286,660
|
|
G |
Hdac2 |
histone deacetylase 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of HDAC2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
|
|
G |
Hebp1 |
heme binding protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:167,974,316...168,003,854
Ensembl chr 4:167,974,319...168,003,854
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of HES1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hes5 |
hes family bHLH transcription factor 5 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of HES5 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:165,522,138...165,523,684
Ensembl chr 5:165,522,234...165,523,001
|
|
G |
Hexa |
hexosaminidase subunit alpha |
decreases expression |
ISO |
azoxystrobin results in decreased expression of HEXA mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:59,936,526...59,961,654
Ensembl chr 8:59,936,660...59,962,013
|
|
G |
Hk1 |
hexokinase 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of HK1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
|
|
G |
Hmmr |
hyaluronan-mediated motility receptor |
increases expression |
ISO |
azoxystrobin results in increased expression of HMMR mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of HMOX1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnrnpm |
heterogeneous nuclear ribonucleoprotein M |
decreases expression |
ISO |
azoxystrobin results in decreased expression of HNRNPM mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:14,438,703...14,476,781
Ensembl chr 7:14,438,688...14,476,762
|
|
G |
Hs3st3b1 |
heparan sulfate-glucosamine 3-sulfotransferase 3B1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HS3ST3B1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:48,561,473...48,593,970
Ensembl chr10:48,561,473...48,593,970
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSD11B2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSD17B10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
|
|
G |
Hsd17b11 |
hydroxysteroid (17-beta) dehydrogenase 11 |
increases expression |
ISO |
azoxystrobin results in increased expression of HSD17B11 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr14:5,693,304...5,743,157
Ensembl chr14:5,711,964...5,743,161
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of HSD17B2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of HSP90AA1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of HSP90B1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPA1B mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of HSPA2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
increases expression |
ISO |
azoxystrobin results in increased expression of HSPA8 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of HSPB1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hspbp1 |
HSPA (Hsp70) binding protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPBP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:69,165,394...69,189,062
Ensembl chr 1:69,165,572...69,244,593
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of HSPD1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Htatsf1 |
HIV-1 Tat specific factor 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of HTATSF1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr X:134,935,426...134,949,607
Ensembl chr X:134,935,426...134,949,607
|
|
G |
Iars2 |
isoleucyl-tRNA synthetase 2, mitochondrial |
increases expression |
ISO |
azoxystrobin results in increased expression of IARS2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr13:96,831,484...96,865,518
Ensembl chr13:96,831,484...96,865,501
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ID1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of IDI1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ier2 |
immediate early response 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of IER2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr19:23,494,551...23,496,075
Ensembl chr19:23,494,184...23,499,211
|
|
G |
Ier3 |
immediate early response 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IER3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifi44l |
interferon-induced protein 44-like |
increases expression |
ISO |
azoxystrobin results in increased expression of IFI44L mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
|
|
G |
Ifitm2 |
interferon induced transmembrane protein 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of IFITM2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:196,051,539...196,052,719
Ensembl chr 1:196,051,537...196,052,741
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of IFITM3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
|
|
G |
Ifna12l |
interferon alpha 12 like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of IFNA12L gene |
CTD |
PMID:33854195 |
|
NCBI chr 5:103,476,362...103,477,427
Ensembl chr 5:103,476,657...103,477,211 Ensembl chr 5:103,476,657...103,477,211 Ensembl chr 5:103,476,657...103,477,211
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
decreases expression |
ISO |
azoxystrobin results in decreased expression of IGF2R mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of IGFBP2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of IGFBP4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
|
|
G |
Igkv2-112l2 |
immunoglobulin kappa variable 2-112 like 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of IGKV2-112L2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 4:102,208,069...102,208,647
Ensembl chr 4:102,208,044...102,208,785
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of IKZF1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
|
|
G |
Ilf2 |
interleukin enhancer binding factor 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of ILF2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:175,952,174...175,971,191
Ensembl chr 2:175,952,186...175,971,337
|
|
G |
Ilk |
integrin-linked kinase |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ILK mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
|
|
G |
Ina |
internexin neuronal intermediate filament protein, alpha |
decreases expression |
ISO |
azoxystrobin results in decreased expression of INA mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:245,896,775...245,908,330
Ensembl chr 1:245,896,775...245,908,330
|
|
G |
Inhbe |
inhibin subunit beta E |
decreases expression |
ISO |
azoxystrobin results in decreased expression of INHBE mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
|
|
G |
Inpp5f |
inositol polyphosphate-5-phosphatase F |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:183,190,480...183,270,276
Ensembl chr 1:183,190,480...183,270,276
|
|
G |
Insig1 |
insulin induced gene 1 |
affects expression |
ISO |
azoxystrobin affects the expression of INSIG1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Iqcb1 |
IQ motif containing B1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IQCB1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:63,905,595...63,960,141
Ensembl chr11:63,905,590...63,960,093
|
|
G |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IRF2BP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642
|
|
G |
Itprip |
inositol 1,4,5-trisphosphate receptor interacting protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ITPRIP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:246,762,804...246,786,379
Ensembl chr 1:246,762,472...246,786,408
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of JUNB mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Katnip |
katanin interacting protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KATNIP gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:180,270,194...180,436,766
Ensembl chr 1:180,269,929...180,436,766
|
|
G |
Kdm3a |
lysine demethylase 3A |
decreases expression |
ISO |
azoxystrobin results in decreased expression of KDM3A mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
|
|
G |
Khdc4 |
KH domain containing 4, pre-mRNA splicing factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of KHDC4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:174,149,059...174,177,816
Ensembl chr 2:174,149,141...174,177,504
|
|
G |
Kif11 |
kinesin family member 11 |
increases expression |
ISO |
azoxystrobin results in increased expression of KIF11 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
|
|
G |
Kif14 |
kinesin family member 14 |
increases expression |
ISO |
azoxystrobin results in increased expression of KIF14 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr13:47,926,975...47,990,598
Ensembl chr13:47,927,044...47,989,164
|
|
G |
Kif15 |
kinesin family member 15 |
increases expression |
ISO |
azoxystrobin results in increased expression of KIF15 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
|
|
G |
Kif20a |
kinesin family member 20A |
increases expression |
ISO |
azoxystrobin results in increased expression of KIF20A mRNA |
CTD |
PMID:33512557 |
|
NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780
|
|
G |
Kif2c |
kinesin family member 2C |
increases expression |
ISO |
azoxystrobin results in increased expression of KIF2C mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
|
|
G |
Kif5c |
kinesin family member 5C |
decreases expression |
ISO |
azoxystrobin results in decreased expression of KIF5C mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:34,032,082...34,185,597
Ensembl chr 3:34,032,105...34,182,413
|
|
G |
Klf10 |
KLF transcription factor 10 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of KLF10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
|
|
G |
Klf2 |
KLF transcription factor 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of KLF2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
|
|
G |
Klhl10 |
kelch-like family member 10 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KLHL10 gene |
CTD |
PMID:33854195 |
|
NCBI chr10:85,376,442...85,392,720
Ensembl chr10:85,376,442...85,392,720
|
|
G |
Krt18 |
keratin 18 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of KRT18 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166 Ensembl chr10:133,157,475...133,161,166
|
|
G |
Ktn1 |
kinectin 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of KTN1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr15:20,913,665...21,002,588
Ensembl chr15:20,914,642...21,002,578
|
|
G |
L1cam |
L1 cell adhesion molecule |
decreases expression |
ISO |
azoxystrobin results in decreased expression of L1CAM mRNA |
CTD |
PMID:33512557 |
|
NCBI chr X:151,597,270...151,623,776
Ensembl chr X:151,597,277...151,623,857
|
|
G |
Lage3 |
L antigen family, member 3 |
increases expression |
ISO |
azoxystrobin results in increased expression of LAGE3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr X:152,138,209...152,139,632
Ensembl chr X:152,138,218...152,139,632
|
|
G |
Lamp1 |
lysosomal-associated membrane protein 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of LAMP1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
|
|
G |
Ldha |
lactate dehydrogenase A |
increases expression |
ISO |
azoxystrobin results in increased expression of LDHA mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Ldlr |
low density lipoprotein receptor |
affects expression |
ISO |
azoxystrobin affects the expression of LDLR mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lep |
leptin |
multiple interactions |
ISO |
[azoxystrobin co-treated with Dietary Fats] affects the expression of LEP protein |
CTD |
PMID:24726979 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lgalsl |
galectin-like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LGALSL mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
|
|
G |
Lhx2 |
LIM homeobox 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of LHX2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 3:22,113,619...22,143,909
Ensembl chr 3:22,126,007...22,143,908
|
|
G |
Litaf |
lipopolysaccharide-induced TNF factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LITAF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
|
|
G |
Lmna |
lamin A/C |
decreases expression |
ISO |
azoxystrobin results in decreased expression of LMNA mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
|
|
G |
Lmod1 |
leiomodin 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of LMOD1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr13:46,754,048...46,796,186
Ensembl chr13:46,754,033...46,794,900
|
|
G |
Lnx2 |
ligand of numb-protein X 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LNX2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:8,005,202...8,070,494
Ensembl chr12:8,005,227...8,070,494
|
|
G |
Loxl1 |
lysyl oxidase-like 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of LOXL1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
|
|
G |
Loxl3 |
lysyl oxidase-like 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LOXL3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 4:115,540,640...115,556,958
Ensembl chr 4:115,540,685...115,557,466
|
|
G |
Lpar2 |
lysophosphatidic acid receptor 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of LPAR2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr16:19,592,067...19,599,998
Ensembl chr16:19,595,655...19,599,998
|
|
G |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LPCAT1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:29,766,070...29,816,401
Ensembl chr 1:29,766,071...29,816,401
|
|
G |
Lpgat1 |
lysophosphatidylglycerol acyltransferase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LPGAT1 gene |
CTD |
PMID:33854195 |
|
NCBI chr13:103,294,622...103,365,372
Ensembl chr13:103,294,528...103,362,333
|
|
G |
Lpin3 |
lipin 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of LPIN3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:149,533,719...149,558,494
Ensembl chr 3:149,534,051...149,558,327
|
|
G |
Lrp1 |
LDL receptor related protein 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of LRP1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
|
|
G |
Lsm5 |
LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated |
increases expression |
ISO |
azoxystrobin results in increased expression of LSM5 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:85,951,073...85,954,289
Ensembl chr 6:104,652,477...104,654,165 Ensembl chr 4:104,652,477...104,654,165
|
|
G |
Lss |
lanosterol synthase |
affects expression |
ISO |
azoxystrobin affects the expression of LSS mRNA |
CTD |
PMID:33512557 |
|
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
|
|
G |
Lta4h |
leukotriene A4 hydrolase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LTA4H mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:27,969,796...28,001,600
Ensembl chr 7:27,969,789...28,001,600
|
|
G |
Lurap1l |
leucine rich adaptor protein 1-like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LURAP1L gene |
CTD |
PMID:33854195 |
|
NCBI chr 5:95,362,005...95,409,439
Ensembl chr 5:95,362,005...95,409,438
|
|
G |
Lyar |
Ly1 antibody reactive |
decreases expression |
ISO |
azoxystrobin results in decreased expression of LYAR mRNA |
CTD |
PMID:33512557 |
|
NCBI chr14:72,576,878...72,590,854
Ensembl chr14:72,576,879...72,590,612
|
|
G |
Maff |
MAF bZIP transcription factor F |
decreases expression |
ISO |
azoxystrobin results in decreased expression of MAFF mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mafg |
MAF bZIP transcription factor G |
decreases expression |
ISO |
azoxystrobin results in decreased expression of MAFG mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Map1b |
microtubule-associated protein 1B |
decreases expression |
ISO |
azoxystrobin results in decreased expression of MAP1B mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:30,817,261...30,910,458
Ensembl chr 2:30,817,261...30,910,317
|
|
G |
Map2 |
microtubule-associated protein 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of MAP2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Map6 |
microtubule-associated protein 6 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of MAP6 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:153,568,020...153,634,415
Ensembl chr 1:153,568,368...153,634,414
|
|
G |
Mapkapk2 |
MAPK activated protein kinase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MAPKAPK2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
|
|
G |
Mapre3 |
microtubule-associated protein, RP/EB family, member 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of MAPRE3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:25,513,800...25,558,876
Ensembl chr 6:25,513,800...25,558,881
|
|
G |
Marf1 |
meiosis regulator and mRNA stability factor 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MARF1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:888,053...932,760
Ensembl chr10:888,076...932,753
|
|
G |
Mat2a |
methionine adenosyltransferase 2A |
decreases expression |
ISO |
azoxystrobin results in decreased expression of MAT2A mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:104,489,877...104,495,447
Ensembl chr 4:104,488,466...104,495,493
|
|
G |
Mcm4 |
minichromosome maintenance complex component 4 |
increases expression |
ISO |
azoxystrobin results in increased expression of MCM4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
|
|
G |
Mdh2 |
malate dehydrogenase 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of MDH2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr12:20,894,269...20,907,225
Ensembl chr12:20,894,262...20,907,271
|
|
G |
Mdk |
midkine |
increases expression |
ISO |
azoxystrobin results in increased expression of MDK mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:77,901,134...77,903,997
Ensembl chr 3:77,901,158...77,903,130
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
increases expression |
ISO |
azoxystrobin results in increased expression of MDM2 protein |
CTD |
PMID:32339800 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of ME1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Med12l |
mediator complex subunit 12L |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MED12L mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:143,253,048...143,576,507
Ensembl chr 2:143,252,139...143,573,741
|
|
G |
Mettl14 |
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:211,530,598...211,546,845
Ensembl chr 2:211,530,602...211,546,821
|
|
G |
Mex3b |
mex-3 RNA binding family member B |
decreases expression |
ISO |
azoxystrobin results in decreased expression of MEX3B mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:136,855,130...136,859,365
Ensembl chr 1:136,855,130...136,859,354
|
|
G |
Mfap5 |
microfibril associated protein 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of MFAP5 gene |
CTD |
PMID:33854195 |
|
NCBI chr 4:155,727,925...155,750,458
Ensembl chr 4:155,727,925...155,750,458
|
|
G |
Mif |
macrophage migration inhibitory factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
|
|
G |
Mir122 |
microRNA 122 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR122 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr18:58,758,703...58,758,787
|
|
G |
Mir130a |
microRNA 130a |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR130A mRNA |
CTD |
PMID:34626815 |
|
NCBI chr 3:69,822,542...69,822,629
Ensembl chr 3:69,822,542...69,822,629
|
|
G |
Mir146a |
microRNA 146a |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MIR146A mRNA |
CTD |
PMID:34626815 |
|
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mir193 |
microRNA 193 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR193 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr10:64,672,354...64,672,439
|
|
G |
Mir22 |
microRNA 22 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR22 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr10:60,307,039...60,307,133
Ensembl chr10:60,307,039...60,307,133
|
|
G |
Mir32 |
microRNA 32 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR32 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr 5:71,596,083...71,596,152
Ensembl chr 5:71,596,083...71,596,152
|
|
G |
Mir33 |
microRNA 33 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR33 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr 7:113,713,855...113,713,923
Ensembl chr 7:113,713,855...113,713,923
|
|
G |
Mir486 |
microRNA 486 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MIR486 mRNA |
CTD |
PMID:34626815 |
|
|
|
G |
Mllt11 |
MLLT11, transcription factor 7 cofactor |
decreases expression |
ISO |
azoxystrobin results in decreased expression of MLLT11 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:182,795,790...182,804,960
Ensembl chr 2:182,795,790...182,797,199
|
|
G |
Mlycd |
malonyl-CoA decarboxylase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MLYCD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:47,447,931...47,463,794
Ensembl chr19:47,447,970...47,463,793
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of MMP2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mocs2 |
molybdenum cofactor synthesis 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MOCS2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:46,504,588...46,516,327
Ensembl chr 2:46,504,588...46,516,324
|
|
G |
Morc3 |
MORC family CW-type zinc finger 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MORC3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:33,151,906...33,194,650
Ensembl chr11:33,152,025...33,194,646
|
|
G |
Morf4l2 |
mortality factor 4 like 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of MORF4L2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr X:100,082,562...100,093,658
Ensembl chr X:100,082,404...100,093,728
|
|
G |
Mre11 |
MRE11 homolog, double strand break repair nuclease |
decreases expression |
ISO |
azoxystrobin results in decreased expression of MRE11 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
|
|
G |
Mrgbp |
MRG domain binding protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MRGBP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:167,697,129...167,700,592
Ensembl chr 3:167,697,185...167,700,592
|
|
G |
Mrnip |
MRN complex interacting protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MRNIP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:34,501,359...34,525,474
Ensembl chr10:34,501,384...34,525,469
|
|
G |
Mrpl3 |
mitochondrial ribosomal protein L3 |
increases expression |
ISO |
azoxystrobin results in increased expression of MRPL3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:105,670,184...105,693,544
Ensembl chr 8:105,670,184...105,693,544
|
|
G |
Mrpl37 |
mitochondrial ribosomal protein L37 |
increases expression |
ISO |
azoxystrobin results in increased expression of MRPL37 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:121,827,892...121,846,187
Ensembl chr 5:121,829,111...121,846,176
|
|
G |
Mrpl44 |
mitochondrial ribosomal protein L44 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPL44 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:81,106,658...81,111,709
Ensembl chr 9:81,106,655...81,112,812
|
|
G |
Mrps17 |
mitochondrial ribosomal protein S17 |
increases expression |
ISO |
azoxystrobin results in increased expression of MRPS17 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr12:26,948,535...26,951,828
Ensembl chr12:26,948,730...26,951,737 Ensembl chr12:26,948,730...26,951,737
|
|
G |
Mrps18b |
mitochondrial ribosomal protein S18B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPS18B mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:2,838,174...2,844,260
Ensembl chr20:2,838,030...2,844,260
|
|
G |
Msh2 |
mutS homolog 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of MSH2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Mt-atp6 |
mitochondrially encoded ATP synthase membrane subunit 6 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ATP6 protein |
CTD |
PMID:32339800 |
|
NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
|
|
G |
Mt-cyb |
mitochondrially encoded cytochrome b |
decreases expression |
ISO |
azoxystrobin results in decreased expression of CYTB protein |
CTD |
PMID:32339800 |
|
NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
|
|
G |
Mt-nd6 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ND6 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
|
|
G |
Mta1 |
metastasis associated 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of MTA1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:132,178,608...132,217,641
Ensembl chr 6:132,178,853...132,217,641
|
|
G |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MTARC1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:96,324,377...96,362,677
Ensembl chr13:96,339,757...96,397,796
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
increases expression |
ISO |
azoxystrobin results in increased expression of MTHFD2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of MYBL1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
|
|
G |
Myl4 |
myosin, light chain 4 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of MYL4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:89,449,456...89,485,365
Ensembl chr10:89,449,443...89,485,363
|
|
G |
Myo10 |
myosin X |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MYO10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:76,100,989...76,305,619
Ensembl chr 2:76,100,987...76,303,030
|
|
G |
N4bp2l2 |
NEDD4 binding protein 2-like 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of N4BP2L2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:137,342...200,292
Ensembl chr12:103,590...197,784
|
|
G |
Nae1 |
NEDD8 activating enzyme E1 subunit 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NAE1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:446,015...472,145
Ensembl chr19:446,000...472,371
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
increases expression |
ISO |
azoxystrobin results in increased expression of NAMPT mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NCAM1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
|
|
G |
Ncan |
neurocan |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NCAN mRNA |
CTD |
PMID:33512557 |
|
NCBI chr16:19,301,969...19,328,436
Ensembl chr16:19,301,969...19,328,436
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NDRG1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Ndufa13 |
NADH:ubiquinone oxidoreductase subunit A13 |
increases expression |
ISO |
azoxystrobin results in increased expression of NDUFA13 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr16:19,526,633...19,533,567
Ensembl chr16:19,526,565...19,535,726 Ensembl chr 7:19,526,565...19,535,726
|
|
G |
Ndufa4 |
Ndufa4, mitochondrial complex associated |
increases expression |
ISO |
azoxystrobin results in increased expression of NDUFA4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:40,002,216...40,009,384
Ensembl chr 4:40,002,216...40,023,920
|
|
G |
Ndufb11 |
NADH:ubiquinone oxidoreductase subunit B11 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of NDUFB11 gene |
CTD |
PMID:33854195 |
|
NCBI chr X:1,572,805...1,575,063
Ensembl chr X:1,572,785...1,575,062
|
|
G |
Ndufb3 |
NADH:ubiquinone oxidoreductase subunit B3 |
increases expression |
ISO |
azoxystrobin results in increased expression of NDUFB3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:60,129,240...60,139,452
Ensembl chr 9:60,129,154...60,139,446
|
|
G |
Ndufv2 |
NADH:ubiquinone oxidoreductase core subunit V2 |
increases expression |
ISO |
azoxystrobin results in increased expression of NDUFV2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:105,690,454...105,710,669
Ensembl chr 9:105,690,455...105,710,713
|
|
G |
Ndufv3 |
NADH:ubiquinone oxidoreductase subunit V3 |
increases expression |
ISO |
azoxystrobin results in increased expression of NDUFV3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr20:9,612,462...9,621,622
Ensembl chr20:9,612,431...9,623,074 Ensembl chr13:9,612,431...9,623,074
|
|
G |
Nefl |
neurofilament light chain |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NEFL mRNA |
CTD |
PMID:33512557 |
|
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
|
|
G |
Nek2 |
NIMA-related kinase 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of NEK2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr13:103,405,818...103,419,063
Ensembl chr13:103,405,819...103,419,051
|
|
G |
Nenf |
neudesin neurotrophic factor |
increases expression |
ISO |
azoxystrobin results in increased expression of NENF mRNA |
CTD |
PMID:33512557 |
|
NCBI chr13:102,888,004...102,894,804
Ensembl chr13:102,888,004...102,894,804
|
|
G |
Nfatc4 |
nuclear factor of activated T-cells 4 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NFATC4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr15:29,286,998...29,314,610
Ensembl chr15:29,305,535...29,314,610
|
|
G |
Nfe2 |
nuclear factor, erythroid 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NFE2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:134,382,758...134,395,364
Ensembl chr 7:134,382,761...134,390,108
|
|
G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
multiple interactions decreases expression |
EXP ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of NFIL3 mRNA azoxystrobin results in decreased expression of NFIL3 mRNA |
CTD |
PMID:33512557 PMID:33854195 |
|
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
|
|
G |
Nfkbib |
NFKB inhibitor beta |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NFKBIB mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
|
|
G |
Nhlh1 |
nescient helix loop helix 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NHLH1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr13:84,517,347...84,522,548
Ensembl chr13:84,517,289...84,525,094
|
|
G |
Nipsnap3b |
nipsnap homolog 3B |
increases expression |
ISO |
azoxystrobin results in increased expression of NIPSNAP3A mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:67,637,644...67,669,698
Ensembl chr 5:67,614,036...67,669,700
|
|
G |
Nos3 |
nitric oxide synthase 3 |
increases expression |
ISO |
azoxystrobin results in increased expression of NOS3 mRNA |
CTD |
PMID:34642769 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Notch1 |
notch receptor 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NOTCH1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Notch3 |
notch receptor 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NOTCH3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025
|
|
G |
Npdc1 |
neural proliferation, differentiation and control, 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NPDC1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:8,220,446...8,226,446
Ensembl chr 3:8,213,663...8,226,866
|
|
G |
Npepl1 |
aminopeptidase-like 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NPEPL1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:162,893,932...162,906,491
Ensembl chr 3:162,893,943...162,906,492
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of NQO1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR0B2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR1D1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
|
|
G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR1D2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
azoxystrobin binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of NR3C1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NR5A1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328
|
|
G |
Nrcam |
neuronal cell adhesion molecule |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NRCAM mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:61,402,813...61,698,536
Ensembl chr 6:61,329,863...61,702,992
|
|
G |
Nrg1 |
neuregulin 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NRG1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Nucks1 |
nuclear casein kinase and cyclin-dependent kinase substrate 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of NUCKS1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:43,345,091...43,374,316
Ensembl chr13:43,345,115...43,370,229
|
|
G |
Nudcd3 |
NudC domain containing 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NUDCD3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr14:80,976,330...81,059,183
Ensembl chr14:80,976,328...81,058,962
|
|
G |
Nusap1 |
nucleolar and spindle associated protein 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of NUSAP1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624
|
|
G |
Oip5 |
Opa interacting protein 5 |
increases expression |
ISO |
azoxystrobin results in increased expression of OIP5 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:106,593,746...106,603,281
Ensembl chr 3:106,593,760...106,603,250
|
|
G |
Olfml2b |
olfactomedin-like 2B |
decreases expression |
ISO |
azoxystrobin results in decreased expression of OLFML2B mRNA |
CTD |
PMID:33512557 |
|
NCBI chr13:82,869,414...82,906,607
Ensembl chr13:82,869,433...82,906,607
|
|
G |
Olr943 |
olfactory receptor 943 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of OLR943 gene |
CTD |
PMID:33854195 |
|
NCBI chr 7:3,389,336...3,390,274
Ensembl chr 7:3,388,200...3,392,130
|
|
G |
Oplah |
5-oxoprolinase (ATP-hydrolysing) |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of OPLAH mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:108,011,472...108,051,751
Ensembl chr 7:108,011,475...108,035,297
|
|
G |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ORAI3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:182,381,196...182,386,055
Ensembl chr 1:182,344,293...182,386,052
|
|
G |
Orc3 |
origin recognition complex, subunit 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of ORC3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:49,123,758...49,181,552
Ensembl chr 5:49,126,955...49,181,633
|
|
G |
P2rx3 |
purinergic receptor P2X 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of P2RX3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178
|
|
G |
Pabir1 |
PP2A Aalpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PABIR1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:222,114,988...222,116,294
Ensembl chr 1:222,112,591...222,116,396
|
|
G |
Papss1 |
3'-phosphoadenosine 5'-phosphosulfate synthase 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of PAPSS1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:220,040,343...220,114,399
Ensembl chr 2:220,040,312...220,114,395
|
|
G |
Parpbp |
PARP1 binding protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of PARPBP gene |
CTD |
PMID:33854195 |
|
NCBI chr 7:22,511,427...22,580,834
Ensembl chr 7:22,511,427...22,573,695
|
|
G |
Pcdha9 |
protocadherin alpha 9 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PCDHA9 mRNA |
CTD |
PMID:33512557 |
|
Ensembl chr18:28,581,225...28,846,211
|
|
G |
Pcmt1 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of PCMT1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:2,111,756...2,160,354
Ensembl chr 1:2,111,763...2,159,201
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression |
ISO |
azoxystrobin results in increased expression of PCNA mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdcd6ip |
programmed cell death 6 interacting protein |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PDCD6IP mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:113,590,998...113,646,795
Ensembl chr 8:113,590,998...113,646,773
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PDK4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
|
|
G |
Pdlim1 |
PDZ and LIM domain 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PDLIM1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:239,042,372...239,091,074
Ensembl chr 1:239,042,385...239,091,076
|
|
G |
Pdp1 |
pyruvate dehydrogenase phosphatase catalytic subunit 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PDP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:25,446,843...25,455,107
Ensembl chr 5:25,446,272...25,455,217
|
|
G |
Pdzd2 |
PDZ domain containing 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PDZD2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 2:61,384,614...61,770,516
Ensembl chr 2:61,386,381...61,770,524
|
|
G |
Peg10 |
paternally expressed 10 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PEG10 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:32,842,441...32,855,639
Ensembl chr 4:32,848,493...32,852,621
|
|
G |
Per1 |
period circadian regulator 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PER1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431
|
|
G |
Per3 |
period circadian regulator 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PER3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607
|
|
G |
Pgf |
placental growth factor |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PGF mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PGK1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
increases expression |
ISO |
azoxystrobin results in increased expression of PHGDH mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PHLDA1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
|
|
G |
Pi4ka |
phosphatidylinositol 4-kinase alpha |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PI4KA mRNA |
CTD |
PMID:33512557 |
|
NCBI chr11:83,609,148...83,726,876
Ensembl chr11:83,609,069...83,724,080
|
|
G |
Pias3 |
protein inhibitor of activated STAT, 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PIAS3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:184,232,546...184,241,455
Ensembl chr 2:184,232,571...184,241,480
|
|
G |
Pigp |
phosphatidylinositol glycan anchor biosynthesis, class P |
increases expression |
ISO |
azoxystrobin results in increased expression of PIGP mRNA |
CTD |
PMID:33512557 |
|
NCBI chr11:33,682,943...33,689,111
Ensembl chr11:33,682,948...33,689,321
|
|
G |
Pink1 |
PTEN induced kinase 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PINK1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Pip4k2b |
phosphatidylinositol-5-phosphate 4-kinase type 2 beta |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PIP4K2B mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:82,706,016...82,734,938
Ensembl chr10:82,701,098...82,734,938
|
|
G |
Pip4p1 |
phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PIP4P1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:24,146,854...24,150,739
Ensembl chr15:24,146,856...24,150,702
|
|
G |
Pirb |
paired Ig-like receptor B |
multiple interactions decreases expression |
EXP ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of LILRB3 mRNA azoxystrobin results in decreased expression of LILRB3 mRNA |
CTD |
PMID:33512557 PMID:33854195 |
|
NCBI chr 1:65,499,195...65,506,666
Ensembl chr 1:65,499,195...65,506,666
|
|
G |
Pitpna |
phosphatidylinositol transfer protein, alpha |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PITPNA mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:60,430,712...60,473,564
Ensembl chr10:60,430,748...60,471,342
|
|
G |
Plekhg5 |
pleckstrin homology and RhoGEF domain containing G5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLEKHG5 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:162,577,999...162,621,518
Ensembl chr 5:162,578,071...162,621,513
|
|
G |
Plk2 |
polo-like kinase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLK2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
|
|
G |
Plpp4 |
phospholipid phosphatase 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PLPP4 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:183,829,794...183,959,319
Ensembl chr 1:183,830,409...183,959,319
|
|
G |
Plxdc2 |
plexin domain containing 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PLXDC2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr17:79,169,238...79,594,279
Ensembl chr17:79,196,369...79,585,282
|
|
G |
Pmm2 |
phosphomannomutase 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PMM2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:6,961,521...6,982,913
Ensembl chr10:6,961,709...6,983,098
|
|
G |
Pmvk |
phosphomevalonate kinase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PMVK mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:174,876,586...174,886,365
Ensembl chr 2:174,876,657...174,886,364
|
|
G |
Pnkd |
PNKD metallo-beta-lactamase domain containing |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PNKD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:75,868,620...75,937,126
Ensembl chr 9:75,867,468...75,937,124
|
|
G |
Pnkp |
polynucleotide kinase 3'-phosphatase |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PNKP mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:95,341,465...95,346,921
Ensembl chr 1:95,341,620...95,346,920
|
|
G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PNRC1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:47,647,070...47,657,832
Ensembl chr 5:47,647,071...47,650,161
|
|
G |
Polb |
DNA polymerase beta |
increases expression |
ISO |
azoxystrobin results in increased expression of POLB mRNA |
CTD |
PMID:33512557 |
|
NCBI chr16:69,379,438...69,402,710
Ensembl chr16:69,379,400...69,404,812
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of POR gene |
CTD |
PMID:33854195 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Pou4f1 |
POU class 4 homeobox 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of POU4F1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr15:81,253,714...81,260,057
Ensembl chr15:81,257,781...81,259,728
|
|
G |
Ppa1 |
inorganic pyrophosphatase 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of PPA1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PPARD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Ppil1 |
peptidylprolyl isomerase like 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PPIL1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr20:7,302,292...7,322,349
Ensembl chr20:7,302,621...7,322,354
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PPP1R15A mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Prdm15 |
PR/SET domain 15 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PRDM15 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:37,164,608...37,225,172
Ensembl chr11:37,165,575...37,222,207
|
|
G |
Prdx1 |
peroxiredoxin 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of PRDX1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prdx2 |
peroxiredoxin 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of PRDX2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Prelid2 |
PRELI domain containing 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PRELID2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr18:33,869,934...33,961,320
Ensembl chr18:33,873,599...33,961,225
|
|
G |
Prelp |
proline and arginine rich end leucine rich repeat protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PRELP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:45,368,407...45,391,480
Ensembl chr13:45,370,533...45,380,270
|
|
G |
Prkag1 |
protein kinase AMP-activated non-catalytic subunit gamma 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PRKAG1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:129,963,105...129,980,532
Ensembl chr 7:129,963,105...129,980,561
|
|
G |
Prkar1a |
protein kinase cAMP-dependent type I regulatory subunit alpha |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PRKAR1A mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:94,621,042...94,639,534
Ensembl chr10:94,620,039...94,639,041
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PRKN mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Proser2 |
proline and serine rich 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PROSER2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:72,151,961...72,187,524
Ensembl chr17:72,151,872...72,185,825
|
|
G |
Prpf39 |
pre-mRNA processing factor 39 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PRPF39 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:83,088,981...83,113,826
Ensembl chr 6:83,088,986...83,113,825
|
|
G |
Prr11 |
proline rich 11 |
increases expression |
ISO |
azoxystrobin results in increased expression of PRR11 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:71,898,858...71,943,325
Ensembl chr10:71,901,202...71,921,012
|
|
G |
Prr7 |
proline rich 7 (synaptic) |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PRR7 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr17:9,164,375...9,173,669
Ensembl chr17:9,165,269...9,172,536
|
|
G |
Psat1 |
phosphoserine aminotransferase 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of PSAT1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
|
|
G |
Psenen |
presenilin enhancer gamma secretase subunit |
increases expression |
ISO |
azoxystrobin results in increased expression of PSENEN mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:85,814,905...85,816,654
Ensembl chr 1:85,814,905...85,816,192
|
|
G |
Psip1 |
PC4 and SRSF1 interacting protein 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PSIP1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:97,847,010...97,879,280
Ensembl chr 5:97,847,015...97,879,257
|
|
G |
Psmc2 |
proteasome 26S subunit, ATPase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:13,255,850...13,270,160
Ensembl chr 4:13,255,856...13,270,185
|
|
G |
Psmc4 |
proteasome 26S subunit, ATPase 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:83,349,127...83,357,497
Ensembl chr 1:83,348,592...83,357,494
|
|
G |
Psmc5 |
proteasome 26S subunit, ATPase 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC5 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:91,187,763...91,193,697
Ensembl chr10:91,187,743...91,213,135
|
|
G |
Psmd2 |
proteasome 26S subunit ubiquitin receptor, non-ATPase 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PSMD2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr11:80,248,364...80,258,991
Ensembl chr11:80,248,364...80,259,043
|
|
G |
Ptk2b |
protein tyrosine kinase 2 beta |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PTK2B mRNA |
CTD |
PMID:33512557 |
|
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
|
|
G |
Ptpa |
protein phosphatase 2 phosphatase activator |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PTPA mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:13,689,742...13,720,287
Ensembl chr 3:13,689,741...13,722,549
|
|
G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PTPRF mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:131,741,959...131,824,000
Ensembl chr 5:131,742,754...131,810,023
|
|
G |
Pus1 |
pseudouridine synthase 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PUS1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr12:45,880,364...45,889,196
Ensembl chr12:45,880,440...45,889,196
|
|
G |
Pus10 |
pseudouridine synthase 10 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PUS10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:97,621,228...97,684,059
Ensembl chr14:97,621,391...97,684,046
|
|
G |
Pus7 |
pseudouridine synthase 7 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of PUS7 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:11,360,169...11,401,139
Ensembl chr 4:11,360,188...11,401,172
|
|
G |
Rab11fip2 |
RAB11 family interacting protein 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of RAB11FIP2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:258,950,535...259,094,555
Ensembl chr 1:258,923,873...259,093,752
|
|
G |
Rab31 |
RAB31, member RAS oncogene family |
decreases expression |
ISO |
azoxystrobin results in decreased expression of RAB31 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:105,246,712...105,382,973
Ensembl chr 9:105,246,709...105,381,253
|
|
G |
Rabep1 |
rabaptin, RAB GTPase binding effector protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RABEP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:55,566,156...55,667,595
Ensembl chr10:55,566,185...55,665,973
|
|
G |
Rabl2 |
RAB, member of RAS oncogene family like 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RABL2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:120,652,175...120,660,906
Ensembl chr 7:120,652,175...120,660,783
|
|
G |
Ramac |
RNA guanine-7 methyltransferase activating subunit |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RAMAC gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:135,708,529...135,714,417
Ensembl chr 1:135,708,535...135,722,151
|
|
G |
Rangap1 |
RAN GTPase activating protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RANGAP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:113,224,695...113,250,441
Ensembl chr 7:113,224,703...113,250,438
|
|
G |
Rars1 |
arginyl-tRNA synthetase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RARS1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:20,270,744...20,295,192
Ensembl chr10:20,270,483...20,295,196
|
|
G |
Rbm14 |
RNA binding motif protein 14 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RBM14 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:202,076,940...202,105,688
Ensembl chr 1:202,078,287...202,105,665 Ensembl chr 1:202,078,287...202,105,665
|
|
G |
Rbm3 |
RNA binding motif protein 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RBM3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:14,348,909...14,352,387
Ensembl chr X:14,348,910...14,353,580
|
|
G |
Rbpms |
RNA binding protein, mRNA processing factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RBPMS gene |
CTD |
PMID:33854195 |
|
NCBI chr16:58,239,370...58,395,424
Ensembl chr16:58,239,474...58,395,426
|
|
G |
Resf1 |
retroelement silencing factor 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RESF1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:182,325,913...182,362,054
Ensembl chr 4:182,335,454...182,362,054
|
|
G |
Rev1 |
REV1, DNA directed polymerase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of REV1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:40,278,100...40,351,764
Ensembl chr 9:40,278,101...40,351,576
|
|
G |
Rfx7 |
regulatory factor X, 7 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RFX7 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:73,254,051...73,339,209
Ensembl chr 8:73,254,051...73,339,209
|
|
G |
Rgcc |
regulator of cell cycle |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RGCC gene |
CTD |
PMID:33854195 |
|
NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141
|
|
G |
Rgs16 |
regulator of G-protein signaling 16 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RGS16 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
|
|
G |
Rhobtb3 |
Rho-related BTB domain containing 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RHOBTB3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:5,363,388...5,419,164
Ensembl chr 2:5,363,388...5,419,041
|
|
G |
Rnase10 |
ribonuclease A family member 10 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of RNASE10 gene |
CTD |
PMID:33854195 |
|
NCBI chr15:24,226,687...24,229,149
Ensembl chr15:24,226,691...24,228,561
|
|
G |
Rnd3 |
Rho family GTPase 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RND3 gene; [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RND3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:35,571,929...35,589,283
Ensembl chr 3:35,571,143...35,589,327
|
|
G |
Rorc |
RAR-related orphan receptor C |
increases activity multiple interactions |
ISO EXP |
azoxystrobin results in increased activity of RORC protein [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RORC mRNA |
CTD |
PMID:20143881 PMID:33854195 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
G |
Rpap3 |
RNA polymerase II associated protein 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of RPAP3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:128,810,820...128,840,006
Ensembl chr 7:128,810,827...128,839,950
|
|
G |
Rpl11 |
ribosomal protein L11 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPL11 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:148,274,060...148,277,708
Ensembl chr 5:148,274,069...148,277,599
|
|
G |
Rpl13a |
ribosomal protein L13A |
increases expression |
ISO |
azoxystrobin results in increased expression of RPL13A mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:95,609,374...95,612,557
Ensembl chr 1:95,609,370...95,620,463
|
|
G |
Rpl17 |
ribosomal protein L17 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPL17 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr18:68,581,141...68,584,253
Ensembl chr18:68,581,098...68,584,253 Ensembl chr 3:68,581,098...68,584,253
|
|
G |
Rpl19 |
ribosomal protein L19 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPL19 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:83,022,503...83,026,030
Ensembl chr10:83,019,257...83,052,112
|
|
G |
Rpl22 |
ribosomal protein L22 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPL22 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:162,835,241...162,843,394
Ensembl chr 5:162,833,740...162,843,368 Ensembl chr 7:162,833,740...162,843,368 Ensembl chr 4:162,833,740...162,843,368
|
|
G |
Rpl26 |
ribosomal protein L26 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPL26 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:53,610,836...53,613,966
Ensembl chr10:53,610,421...53,613,966
|
|
G |
Rpl32 |
ribosomal protein L32 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPL32 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:148,864,048...148,867,612
Ensembl chr 4:148,864,044...148,867,612 Ensembl chr 3:148,864,044...148,867,612
|
|
G |
Rpl36 |
ribosomal protein L36 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPL36 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:1,441,986...1,447,397
Ensembl chr 6:98,809,534...98,809,897 Ensembl chr 5:98,809,534...98,809,897
|
|
G |
Rpl36al1 |
ribosomal protein L36A like 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPL36AL mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:87,654,808...87,656,202
Ensembl chr X:97,766,179...97,768,892 Ensembl chr10:97,766,179...97,768,892 Ensembl chr20:97,766,179...97,768,892
|
|
G |
Rpl4 |
ribosomal protein L4 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPL4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:64,671,177...64,676,301
Ensembl chr 8:64,671,160...64,676,306
|
|
G |
Rpl6 |
ribosomal protein L6 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPL6 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr12:35,347,493...35,352,011
Ensembl chr12:35,347,497...35,351,921
|
|
G |
Rpl8 |
ribosomal protein L8 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPL8 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:108,626,194...108,628,485
Ensembl chr 7:108,622,324...108,628,482 Ensembl chr 3:108,622,324...108,628,482
|
|
G |
Rpl9 |
ribosomal protein L9 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPL9 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr14:42,893,945...42,897,140
Ensembl chr14:42,893,942...42,897,136 Ensembl chr 3:42,893,942...42,897,136 Ensembl chr 1:42,893,942...42,897,136
|
|
G |
Rps13 |
ribosomal protein S13 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPS13 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:170,572,925...170,575,355
Ensembl chr 1:170,572,921...170,575,355 Ensembl chr 3:170,572,921...170,575,355
|
|
G |
Rps18 |
ribosomal protein S18 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPS18 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr20:4,931,427...4,935,538
Ensembl chr20:4,931,768...4,938,315
|
|
G |
Rps2 |
ribosomal protein S2 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPS2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:13,747,316...13,749,165
Ensembl chr10:13,747,301...13,749,163
|
|
G |
Rps20 |
ribosomal protein S20 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPS20 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:16,819,095...16,820,476
Ensembl chr 5:16,819,304...16,820,475 Ensembl chr 9:16,819,304...16,820,475 Ensembl chr 3:16,819,304...16,820,475 Ensembl chr 5:16,819,304...16,820,475
|
|
G |
Rps25 |
ribosomal protein s25 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPS25 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:44,733,623...44,735,999
Ensembl chr 8:44,733,029...44,737,271 Ensembl chr 8:44,733,029...44,737,271
|
|
G |
Rps27a |
ribosomal protein S27a |
increases expression |
ISO |
azoxystrobin results in increased expression of RPS27A mRNA |
CTD |
PMID:33512557 |
|
NCBI chr14:103,285,734...103,288,011
Ensembl chr14:103,285,734...103,288,011 Ensembl chr 5:103,285,734...103,288,011 Ensembl chr 5:103,285,734...103,288,011
|
|
G |
Rps27l |
ribosomal protein S27-like |
increases expression |
ISO |
azoxystrobin results in increased expression of RPS27L mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418 Ensembl chr12:67,562,483...67,567,418 Ensembl chr 2:67,562,483...67,567,418
|
|
G |
Rps5 |
ribosomal protein S5 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPS5 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:73,538,776...73,543,073
Ensembl chr 1:73,538,776...73,543,073
|
|
G |
Rps6 |
ribosomal protein S6 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPS6 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
|
|
G |
Rps7 |
ribosomal protein S7 |
increases expression |
ISO |
azoxystrobin results in increased expression of RPS7 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:45,266,200...45,271,064
Ensembl chr 6:45,223,980...45,271,145 Ensembl chr 5:45,223,980...45,271,145
|
|
G |
Rrp12 |
ribosomal RNA processing 12 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of RRP12 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:240,672,378...240,705,992
Ensembl chr 1:240,672,382...240,706,018
|
|
G |
Ruvbl1 |
RuvB-like AAA ATPase 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of RUVBL1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:120,932,486...120,967,400
Ensembl chr 4:120,932,417...121,029,384
|
|
G |
Rxylt1 |
ribitol xylosyltransferase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of RXYLT1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 7:57,770,841...57,782,695
Ensembl chr 7:57,770,842...57,782,657
|
|
G |
S100a4 |
S100 calcium-binding protein A4 |
increases expression |
ISO |
azoxystrobin results in increased expression of S100A4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
|
|
G |
Sall4 |
spalt-like transcription factor 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SALL4 gene |
CTD |
PMID:33854195 |
|
NCBI chr 3:157,474,067...157,491,055
Ensembl chr 3:157,474,642...157,490,822
|
|
G |
Sardh |
sarcosine dehydrogenase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SARDH mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:10,510,553...10,575,342
Ensembl chr 3:10,510,553...10,573,874
|
|
G |
Satb1 |
SATB homeobox 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SATB1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:4,677,817...4,773,061
Ensembl chr 9:4,680,920...4,753,251
|
|
G |
Scnn1a |
sodium channel epithelial 1 subunit alpha |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SCNN1A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:158,122,962...158,146,184
Ensembl chr 4:158,122,962...158,146,181
|
|
G |
Scrn1 |
secernin 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SCRN1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:83,632,125...83,694,225
Ensembl chr 4:83,632,131...83,693,852
|
|
G |
Sdhb |
succinate dehydrogenase complex iron sulfur subunit B |
increases expression |
ISO |
azoxystrobin results in increased expression of SDHB mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:153,264,906...153,285,570
Ensembl chr 5:153,264,899...153,314,293
|
|
G |
Sdk2 |
sidekick cell adhesion molecule 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SDK2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:98,824,916...99,102,590
Ensembl chr10:98,828,348...99,101,759
|
|
G |
Sdr42e1 |
short chain dehydrogenase/reductase family 42E, member 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SDR42E1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:45,715,366...45,727,901
Ensembl chr19:45,715,399...45,727,901
|
|
G |
Sec11a |
SEC11 homolog A, signal peptidase complex subunit |
increases expression |
ISO |
azoxystrobin results in increased expression of SEC11A mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:134,881,448...134,909,427
Ensembl chr 1:134,875,265...134,915,069
|
|
G |
Sema4b |
semaphorin 4B |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SEMA4B mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:134,136,646...134,177,777
Ensembl chr 1:134,149,536...134,177,775
|
|
G |
Sema6d |
semaphorin 6D |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SEMA6D mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:111,883,415...111,941,100
Ensembl chr 3:111,883,872...111,941,094
|
|
G |
Serpina1 |
serpin family A member 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SERPINA1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
|
|
G |
Sesn2 |
sestrin 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SESN2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
|
|
G |
Setd6 |
SET domain containing 6, protein lysine methyltransferase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SETD6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:9,343,309...9,350,477
Ensembl chr19:9,347,458...9,350,453
|
|
G |
Sfrp2 |
secreted frizzled-related protein 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SFRP2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063
|
|
G |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
affects expression |
ISO |
azoxystrobin affects the expression of SGK2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
|
|
G |
Sh3bp2 |
SH3-domain binding protein 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SH3BP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:76,176,097...76,213,300
Ensembl chr14:76,176,101...76,213,251
|
|
G |
Shc1 |
SHC adaptor protein 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SHC1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
|
|
G |
Sigirr |
single Ig and TIR domain containing |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SIGIRR mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:196,195,363...196,208,692
Ensembl chr 1:196,199,462...196,202,269
|
|
G |
Sik2 |
salt-inducible kinase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SIK2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:51,225,543...51,325,343
Ensembl chr 8:51,225,543...51,325,415
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SLC11A2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
|
|
G |
Slc12a6 |
solute carrier family 12, member 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC12A6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:99,071,577...99,170,266
Ensembl chr 3:99,071,391...99,170,258
|
|
G |
Slc17a6 |
solute carrier family 17 member 6 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SLC17A6 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:101,212,489...101,252,543
Ensembl chr 1:101,212,489...101,252,542
|
|
G |
Slc1a2 |
solute carrier family 1 member 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SLC1A2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
|
|
G |
Slc20a1 |
solute carrier family 20 member 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC20A1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:116,427,095...116,441,049
Ensembl chr 3:116,427,098...116,441,051
|
|
G |
Slc25a39 |
solute carrier family 25, member 39 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC25A39 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:87,362,494...87,367,358
Ensembl chr10:87,362,490...87,367,260
|
|
G |
Slc25a4 |
solute carrier family 25 member 4 |
increases expression |
ISO |
azoxystrobin results in increased expression of SLC25A4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr16:46,072,935...46,076,730
Ensembl chr16:46,072,939...46,076,733
|
|
G |
Slc25a5 |
solute carrier family 25 member 5 |
increases expression |
ISO |
azoxystrobin results in increased expression of SLC25A5 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr X:116,031,896...116,034,963
Ensembl chr X:116,031,803...116,034,967
|
|
G |
Slc25a5-ps11 |
solute carrier family 25 member 5, pseudogene 11 |
increases expression |
ISO |
azoxystrobin results in increased expression of SLC25A6 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr18:68,571,222...68,572,461
Ensembl chr18:68,571,300...68,572,199
|
|
G |
Slc26a6 |
solute carrier family 26 member 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC26A6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:109,558,968...109,569,778
Ensembl chr 8:109,559,642...109,569,778
|
|
G |
Slc37a2 |
solute carrier family 37 member 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC37A2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:36,945,787...36,971,748
Ensembl chr 8:36,946,930...36,971,482
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SLC3A2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
affects expression |
ISO |
azoxystrobin affects the expression of SLC7A5 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Slk |
STE20-like kinase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SLK gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:246,473,712...246,529,643
Ensembl chr 1:246,473,712...246,526,530
|
|
G |
Smad3 |
SMAD family member 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SMAD3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Smad7 |
SMAD family member 7 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SMAD7 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
|
|
G |
Smpx |
small muscle protein, X-linked |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SMPX gene |
CTD |
PMID:33854195 |
|
NCBI chr X:37,233,209...37,292,266
Ensembl chr X:37,234,294...37,276,708
|
|
G |
Snca |
synuclein alpha |
increases expression |
ISO |
azoxystrobin results in increased expression of SNCA mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Snrnp200 |
small nuclear ribonucleoprotein U5 subunit 200 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SNRNP200 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:114,428,854...114,458,194
Ensembl chr 3:114,428,854...114,458,182
|
|
G |
Snx13 |
sorting nexin 13 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SNX13 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:51,758,258...51,862,260
Ensembl chr 6:51,753,036...51,860,224
|
|
G |
Snx4 |
sorting nexin 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SNX4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:67,460,872...67,518,143
Ensembl chr11:67,460,870...67,518,174
|
|
G |
Socs2 |
suppressor of cytokine signaling 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SOCS2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SOCS3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sod3 |
superoxide dismutase 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SOD3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Sohlh1 |
spermatogenesis and oogenesis specific basic helix-loop-helix 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SOHLH1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 3:8,662,995...8,667,521
Ensembl chr 3:8,663,318...8,667,388
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SOX9 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
|
|
G |
Spag1 |
sperm associated antigen 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SPAG1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:67,361,474...67,421,369
Ensembl chr 7:67,361,477...67,421,368
|
|
G |
Spag5 |
sperm associated antigen 5 |
increases expression |
ISO |
azoxystrobin results in increased expression of SPAG5 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:63,198,717...63,216,746
Ensembl chr10:63,198,768...63,216,745
|
|
G |
Spdef |
SAM pointed domain containing ets transcription factor |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SPDEF mRNA |
CTD |
PMID:33512557 |
|
NCBI chr20:5,771,440...5,785,893
Ensembl chr20:5,771,441...5,785,893
|
|
G |
Spred2 |
sprouty-related, EVH1 domain containing 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SPRED2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr14:94,149,210...94,250,787
Ensembl chr14:94,148,837...94,249,162
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SRD5A1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SRD5A2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with Dietary Fats] affects the expression of SREBF1 mRNA |
CTD |
PMID:24726979 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srm |
spermidine synthase |
increases expression |
ISO |
azoxystrobin results in increased expression of SRM mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
|
|
G |
Srp72 |
signal recognition particle 72 |
increases expression |
ISO |
azoxystrobin results in increased expression of SRP72 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr14:31,168,175...31,195,717
Ensembl chr14:31,168,293...31,195,729
|
|
G |
Srrm2 |
serine/arginine repetitive matrix 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRRM2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:12,815,471...12,848,750
Ensembl chr10:12,815,471...12,848,751
|
|
G |
Srsf2 |
serine and arginine rich splicing factor 2 |
increases expression |
ISO |
azoxystrobin results in increased expression of SRSF2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
|
|
G |
Srsf5 |
serine and arginine rich splicing factor 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRSF5 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:100,605,456...100,610,177
|
|
G |
Stard9 |
StAR-related lipid transfer domain containing 9 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of STARD9 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:107,581,097...107,672,746
Ensembl chr 3:107,581,164...107,673,898
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of STAT4 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stk10 |
serine/threonine kinase 10 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of STK10 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:17,117,860...17,212,065
Ensembl chr10:17,117,878...17,212,061
|
|
G |
Stk25 |
serine/threonine kinase 25 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of STK25 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:94,161,834...94,174,095
Ensembl chr 9:94,161,836...94,174,244
|
|
G |
Stmn1 |
stathmin 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of STMN1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
|
|
G |
Susd2 |
sushi domain containing 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SUSD2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:13,017,516...13,024,820
Ensembl chr20:13,017,477...13,024,903
|
|
G |
Suv39h1 |
SUV39H1 histone lysine methyltransferase |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SUV39H1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr X:14,421,028...14,433,993
Ensembl chr X:14,421,109...14,433,982
|
|
G |
Suv39h1-ps1 |
SUV39H1 histone lysine methyltransferase, pseudogene 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SUV39H1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr X:141,792,589...141,795,257
|
|
G |
Sympk |
symplekin scaffold protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SYMPK mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:78,672,372...78,700,684
Ensembl chr 1:78,672,378...78,700,684
|
|
G |
Syngr3 |
synaptogyrin 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of SYNGR3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:13,710,553...13,715,309
Ensembl chr10:13,704,998...13,715,669
|
|
G |
Tacc3 |
transforming, acidic coiled-coil containing protein 3 |
increases expression |
ISO |
azoxystrobin results in increased expression of TACC3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr14:77,051,209...77,065,343
Ensembl chr14:77,051,215...77,065,219
|
|
G |
Tagln |
transgelin |
increases expression |
ISO |
azoxystrobin results in increased expression of TAGLN mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
|
|
G |
Tat |
tyrosine aminotransferase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TAT mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
|
|
G |
Tbc1d4 |
TBC1 domain family, member 4 |
multiple interactions |
ISO |
[azoxystrobin co-treated with Dietary Fats] affects the phosphorylation of TBC1D4 protein |
CTD |
PMID:24726979 |
|
NCBI chr15:78,256,030...78,434,168
Ensembl chr15:78,257,121...78,434,265
|
|
G |
Tceal9 |
transcription elongation factor A like 9 |
increases expression |
ISO |
azoxystrobin results in increased expression of TCEAL9 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr X:99,245,645...99,247,720
Ensembl chr X:99,228,458...99,247,763
|
|
G |
Tdp2 |
tyrosyl-DNA phosphodiesterase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TDP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:40,228,943...40,240,337
Ensembl chr17:40,228,947...40,240,313
|
|
G |
Tead2 |
TEA domain transcription factor 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TEAD2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:95,702,366...95,719,186
Ensembl chr 1:95,703,005...95,719,186
|
|
G |
Tecr |
trans-2,3-enoyl-CoA reductase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TECR mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:24,526,700...24,568,168
Ensembl chr19:24,541,615...24,568,168
|
|
G |
Tert |
telomerase reverse transcriptase |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TERT mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tgds |
TDP-glucose 4,6-dehydratase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TGDS mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:95,175,064...95,195,555
Ensembl chr15:95,174,608...95,195,554
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of TGFB1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb3 |
transforming growth factor, beta 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TGFB3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
|
|
G |
Tgfbi |
transforming growth factor, beta induced |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TGFBI mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:7,955,603...7,984,903
Ensembl chr17:7,955,603...7,985,240
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TGFBR2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Timmdc1 |
translocase of inner mitochondrial membrane domain containing 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of TIMMDC1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr11:62,228,990...62,259,389
Ensembl chr11:62,229,058...62,254,699
|
|
G |
Tjap1 |
tight junction associated protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TJAP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:14,701,418...14,725,623
Ensembl chr 9:14,701,468...14,725,751
|
|
G |
Tkt |
transketolase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TKT mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
|
|
G |
Tm7sf3 |
transmembrane 7 superfamily member 3 |
increases expression |
ISO |
azoxystrobin results in increased expression of TM7SF3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 4:179,518,127...179,550,154
Ensembl chr 4:179,518,130...179,550,154
|
|
G |
Tmbim6 |
transmembrane BAX inhibitor motif containing 6 |
multiple interactions increases expression |
EXP ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TMBIM6 mRNA azoxystrobin results in increased expression of TMBIM6 mRNA |
CTD |
PMID:33512557 PMID:33854195 |
|
NCBI chr 7:130,527,313...130,542,567
Ensembl chr 7:130,527,316...130,543,633
|
|
G |
Tmem185a |
transmembrane protein 185A |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TMEM185A mRNA |
CTD |
PMID:33512557 |
|
NCBI chr X:149,143,026...149,167,757
Ensembl chr X:149,143,031...149,167,757
|
|
G |
Tmem268 |
transmembrane protein 268 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:76,974,827...77,001,457
Ensembl chr 5:76,977,310...77,001,452
|
|
G |
Tmem65 |
transmembrane protein 65 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TMEM65 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:90,336,997...90,378,930
Ensembl chr 7:90,274,142...90,379,474
|
|
G |
Tmem97 |
transmembrane protein 97 |
increases expression |
ISO |
azoxystrobin results in increased expression of TMEM97 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730
|
|
G |
Tmt1b |
thiol methyltransferase 1B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TMT1B mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:1,388,876...1,391,526
Ensembl chr 7:1,388,879...1,391,526
|
|
G |
Tnc |
tenascin C |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TNC mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [azoxystrobin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; azoxystrobin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] |
CTD |
PMID:33226166 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip2 |
TNF alpha induced protein 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TNFAIP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:130,476,889...130,489,914
|
|
G |
Tnip1 |
TNFAIP3 interacting protein 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TNIP1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:39,037,048...39,084,328
Ensembl chr10:39,037,058...39,077,625
|
|
G |
Tor3a |
torsin family 3, member A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TOR3A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:68,769,893...68,798,738
Ensembl chr13:68,769,605...68,798,475
|
|
G |
Tpm1 |
tropomyosin 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TPM1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
|
|
G |
Tpx2 |
TPX2, microtubule nucleation factor |
increases expression |
ISO |
azoxystrobin results in increased expression of TPX2 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:141,318,428...141,360,684
Ensembl chr 3:141,318,455...141,360,468
|
|
G |
Traf3ip2 |
Traf3 interacting protein 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAF3IP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:43,011,405...43,054,654
Ensembl chr20:43,011,450...43,054,667
|
|
G |
Trafd1 |
TRAF type zinc finger domain containing 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAFD1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:35,165,606...35,179,525
Ensembl chr12:35,165,606...35,179,525
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression |
ISO |
azoxystrobin results in increased expression of TRIB3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Trim13 |
tripartite motif-containing 13 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TRIM13 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr15:35,733,548...35,772,676
Ensembl chr15:35,734,107...35,772,677
|
|
G |
Trim34 |
tripartite motif-containing 34 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRIM34 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:158,707,172...158,720,214
Ensembl chr 1:158,707,172...158,718,674
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TRPV1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
|
|
G |
Tsc22d3 |
TSC22 domain family, member 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TSC22D3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
|
|
G |
Tspan3 |
tetraspanin 3 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TSPAN3 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 8:56,546,067...56,569,815
Ensembl chr 8:56,546,069...56,569,880
|
|
G |
Tst |
thiosulfate sulfurtransferase |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TST mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:109,948,061...109,955,378
Ensembl chr 7:109,948,062...109,957,216
|
|
G |
Tuba1b |
tubulin, alpha 1B |
increases expression |
ISO |
azoxystrobin results in increased expression of TUBA1B mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 7:130,090,663...130,093,644
Ensembl chr 7:130,081,032...130,196,186
|
|
G |
Tubb2a |
tubulin, beta 2A class IIa |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TUBB2A mRNA |
CTD |
PMID:33512557 |
|
NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714
|
|
G |
Tubb2b |
tubulin, beta 2B class IIb |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TUBB2B mRNA |
CTD |
PMID:33512557 |
|
NCBI chr17:30,747,734...30,750,781
Ensembl chr17:30,747,734...30,750,638
|
|
G |
Txnip |
thioredoxin interacting protein |
decreases expression |
ISO |
azoxystrobin results in decreased expression of TXNIP mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
|
|
G |
Tyms |
thymidylate synthetase |
affects expression |
ISO |
azoxystrobin affects the expression of TYMS mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Uba3 |
ubiquitin-like modifier activating enzyme 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of UBA3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:129,789,526...129,810,707
Ensembl chr 4:129,789,204...129,810,606
|
|
G |
Ubb |
ubiquitin B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBB mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:47,247,630...47,249,335
Ensembl chr10:47,245,637...47,249,333
|
|
G |
Ubc |
ubiquitin C |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBC mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:31,239,149...31,243,924
Ensembl chr12:31,239,152...31,243,925
|
|
G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
increases expression |
ISO |
azoxystrobin results in increased expression of UBE2C mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
|
|
G |
Uchl1 |
ubiquitin C-terminal hydrolase L1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of UCHL1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
|
|
G |
Uckl1 |
uridine-cytidine kinase 1-like 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of UCKL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:168,674,849...168,687,513
Ensembl chr 3:168,674,849...168,698,091
|
|
G |
Uhrf1 |
ubiquitin-like with PHD and ring finger domains 1 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of UHRF1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
|
|
G |
Unc45a |
unc-45 myosin chaperone A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UNC45A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:134,281,930...134,296,661
Ensembl chr 1:134,281,933...134,301,586
|
|
G |
Usp2 |
ubiquitin specific peptidase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of USP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331
|
|
G |
Usp40 |
ubiquitin specific peptidase 40 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of USP40 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:88,607,920...88,678,940
Ensembl chr 9:88,607,930...88,678,914
|
|
G |
Usp7 |
ubiquitin specific peptidase 7 |
decreases expression |
ISO |
azoxystrobin results in decreased expression of USP7 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:6,880,684...6,925,355
Ensembl chr10:6,828,795...6,925,355
|
|
G |
Vdac1 |
voltage-dependent anion channel 1 |
increases expression |
ISO |
azoxystrobin results in increased expression of VDAC1 mRNA |
CTD |
PMID:33512557 |
|
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions affects expression |
EXP ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of VEGFA mRNA azoxystrobin affects the expression of VEGFA mRNA |
CTD |
PMID:33512557 | |